Scilex Holding Company Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Scilex Holding Company (SCLX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $320.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Notes
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2023-03-07
- Scilex Holding Company right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $320.00K.
- Scilex Holding Company right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|
| 2022-12-31 | $320.00K 10-K · filed 2023-03-07 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |